Surge in Pharmaceutical Demand Propels Growth Of Small-Molecule CMO/CDMO Market Is Supporting Development Across The Small Molecule CMO/CDMO Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Small Molecule CMO/CDMO Market?

The small molecule cmo/cdmo market size has experienced robust growth in recent years. It is anticipated to increase from $54.42 billion in 2025 to $58.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the past can be ascribed to an increase in generic drug manufacturing, the rising incidence of chronic diseases, the enlargement of pharmaceutical R&D activities, the outsourcing of drug production, and a regulatory drive for enhanced quality and safety.

The small molecule cmo/cdmo market size is anticipated to experience substantial expansion over the forthcoming years. Its valuation is projected to reach **$78.41 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%**. This projected growth is primarily driven by factors such as the increasing requirement for personalized medical treatments, greater capital expenditure in biologics and combination small-molecule therapies, market penetration in developing regions, innovations in synthesis and formulation techniques, and an escalating necessity for quicker regulatory clearances. Key developments expected during this timeframe encompass the broadening of contract development and manufacturing offerings, a greater embrace of continuous manufacturing methodologies, an uptick in bespoke synthesis of small-molecule APIs, an intensified emphasis on adherence to regulations and quality control, and the formation of strategic alliances between pharmaceutical firms and CMOs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

What Influential Factors Are Boosting The Small Molecule CMO/CDMO Market Demand?

The future expansion of the small-molecule CMO/CDMO market is anticipated due to increasing pharmaceutical demand. The pharmaceutical industry encompasses the entire process of drug and medicine creation, from initial discovery to development and production, undertaken by both government and private organizations. In the pharmaceutical sector, small-molecule CMO/CDMO services are utilized for outsourcing activities such as the development, production, and packaging of small-molecule drugs, which assists pharmaceutical firms in cutting expenses, conserving time, and optimizing operations. For example, data from January 2023, provided by Cardinal Health Inc., a US-based healthcare company, revealed that as of January 2022, the U.S. had 33 biosimilar products approved by the FDA, with 21 of them available on the market. By 2023, this figure increased, with 40 FDA-approved biosimilars and 25 commercially accessible. Consequently, the heightened demand for pharmaceuticals is stimulating the expansion of the small-molecule CMO/CDMO market.

How Is The Small Molecule CMO/CDMO Market Structured Across Different Market Segments?

The small molecule cmo/cdmo market covered in this report is segmented –

1) By Product: Small Molecule Drug Product, Small Molecule API

2) By Stage Type: Clinical, Commercial, Preclinical

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics

4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

What Trends Are Driving Changes In The Small Molecule CMO/CDMO Market?

Leading companies engaged in the small-molecule CMO/CDMO market are concentrating on innovative technologies, exemplified by the advanced small-molecule platform located in Shanghai, to improve their CDMO services. This sophisticated small-molecule platform stands as a leading example of technological advancements aimed at developing and manufacturing small-molecule drugs, thereby producing pharmaceutical compounds that are safer, more effective, and more efficiently created. For instance, in June 2023, Porton Pharma Solutions Ltd., a pharmaceutical company based in China, introduced a cutting-edge small-molecule platform in Shanghai, which served to upgrade CDMO services. An advanced small-molecule platform represents a comprehensive strategy, bringing together pioneering technologies and methodologies to enhance the entire progression of small molecule pharmaceuticals, offering integrated one-stop-shop solutions, end-to-end capabilities, flexibility, availability, and digital transformation.

Who Are The Firms Contributing To The Small Molecule CMO/CDMO Market Ecosystem?

Major companies operating in the small molecule cmo/cdmo market are Patheon NV (Thermo Fisher Scientific), Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services

Access The Complete Small Molecule CMO/CDMO Market Report:

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Which Area Represents The Largest Portion Of The Small Molecule CMO/CDMO Market?

North America was the largest region in the small molecule CMO/CDMO market in 2025. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Small Molecule CMO/CDMO Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

Browse Through More Reports Similar to the Global Small Molecule CMO/CDMO Market 2026, By The Business Research Company

Small Molecule Cmo Or Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

Small Molecule Innovator Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-innovator-cdmo-global-market-report

Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795